Related references
Note: Only part of the references are listed.Dose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naive patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the ACHIEVE trial
M. -F. Yuen et al.
JOURNAL OF HEPATOLOGY (2018)
RNA interference therapy with ARC-520 Injection results in long term off-therapy antigen reductions in treatment naive, HBeAg positive and negative patients with chronic HBV
M. -F. Yuen et al.
JOURNAL OF HEPATOLOGY (2018)
First report of occult hepatitis B infection among ART naive HIV seropositive individuals in Maputo, Mozambique
Awa Abdul Carimo et al.
PLOS ONE (2018)
An OX40/OX40L interaction directs successful immunity to hepatitis B virus
Jean Publicover et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Reduction in Liver Transplant Wait-Listing in the Era of Direct-Acting Antiviral Therapy
Jennifer A. Flemming et al.
HEPATOLOGY (2017)
Hepatitis B core protein as a therapeutic target
Lung-Yi Mak et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
Rohit Loomba et al.
GASTROENTEROLOGY (2017)
Role of Surface Antibody in Hepatitis B Reactivation in Patients With Resolved Infection and Hematologic Malignancy: A Meta-analysis
Sonali Paul et al.
HEPATOLOGY (2017)
Long-Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B After Liver Transplantation: Results up to 8 Years
James Fung et al.
HEPATOLOGY (2017)
PRMT5 Restricts Hepatitis B Virus Replication Through Epigenetic Repression of Covalently Closed Circular DNA Transcription and Interference With Pregenomic RNA Encapsidation
Wen Zhang et al.
HEPATOLOGY (2017)
Hepatitis B Cure: From Discovery to Regulatory Approval
Anna S. Lok et al.
HEPATOLOGY (2017)
Hepatitis B Reactivation in Hepatitis B and C Coinfected Patients Treated With Antiviral Agents: A Systematic Review and Meta-analysis
Guofeng Chen et al.
HEPATOLOGY (2017)
Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma
An-Ye Zhang et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B
Fanny Lebosse et al.
JOURNAL OF HEPATOLOGY (2017)
Serum HBV pgRNA as a clinical marker for cccDNA activity
Katja Giersch et al.
JOURNAL OF HEPATOLOGY (2017)
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Ching-Lung Lai et al.
JOURNAL OF HEPATOLOGY (2017)
The role of quantitative hepatitis B surface antigen revisited
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mohsen Naghavi et al.
LANCET (2017)
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong et al.
LIVER INTERNATIONAL (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
Sabrina Schreiner et al.
VIRUSES-BASEL (2017)
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Thomas Tu et al.
VIRUSES-BASEL (2017)
Identifying and Characterizing Interplay between Hepatitis B Virus X Protein and Smc5/6
Christine M. Livingston et al.
VIRUSES-BASEL (2017)
Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
Eiichi Ogawa et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Yuk-Fai Lam et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
En-Qiang Chen et al.
SCIENTIFIC REPORTS (2017)
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences
S. Pol et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
Michel Bazinet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype
M. Riveiro-Barciela et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Hepatitis B in patients with hematological diseases: An update
Chiara Coluccio et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Management of hepatitis B in special populations
Kali Zhou et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants
Angela M. Lam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Hepatitis B Core-Related Antigen: A Possible Indicator for the Termination of Prophylactic Nucleos(t)ide Analogue Therapy in Patients After Immunosuppressive Therapy
Hienori Toyoda et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the US Food and Drug Administration Adverse Event Reporting System
Susan J. Bersoff-Matcha et al.
ANNALS OF INTERNAL MEDICINE (2017)
Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics
Timothy M. Block et al.
CLINICAL INFECTIOUS DISEASES (2017)
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial
Marc Bourliere et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV
Xing-Liang Zhao et al.
GUT (2016)
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis
Robert S. Brown et al.
HEPATOLOGY (2016)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
Kyu Sik Jung et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma
Masao Honda et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
Joseph Ahn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
C. S. Voican et al.
ANNALS OF ONCOLOGY (2016)
Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
Andrew Vaillant
ANTIVIRAL RESEARCH (2016)
Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan
Yen-Hsuan Ni et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)
Donna M. Evon et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
The Concept of Immune Tolerance in Chronic Hepatitis B Virus Infection Is Alive and Well
David R. Milich
GASTROENTEROLOGY (2016)
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
William S. Mason et al.
GASTROENTEROLOGY (2016)
Interferon-gamma and Tumor Necrosis Factor-alpha Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis
Yuchen Xia et al.
GASTROENTEROLOGY (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Prevention and management of hepatitis B virus reactivation in cancer patients
Ka-Shing Cheung et al.
HEPATOLOGY INTERNATIONAL (2016)
Need to improve awareness and management of hepatitis B reactivation in patients receiving immunosuppressive therapy
Man-Fung Yuen
HEPATOLOGY INTERNATIONAL (2016)
Isolated Hepatitis B Core Antibody is Associated With Advanced Hepatic Fibrosis in HIV/HCV Infection But Not in HIV Infection Alone
Debika Bhattacharya et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Chronic Hepatitis B Virus Infection Disease Revisit and Management Recommendations
Man-Fung Yuen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
The role of innate immunity in the immunopathology and treatment of HBV infection
Mala K. Maini et al.
JOURNAL OF HEPATOLOGY (2016)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Measurement of the hepatitis B core-related antigen is valuable for predicting the pathological status of liver tissues in chronic hepatitis B patients
Zhan-Qing Zhang et al.
JOURNAL OF VIROLOGICAL METHODS (2016)
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Tung-Hung Su et al.
LIVER INTERNATIONAL (2016)
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Calvin Q. Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus
B. Adil et al.
TRANSPLANTATION PROCEEDINGS (2016)
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis
Shevanthi Nayagam et al.
LANCET GLOBAL HEALTH (2016)
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Maria Buti et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Immune responses and immunopathology in acute and chronic viral hepatitis
Eui-Cheol Shin et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy
Eisuke Murakami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
NTCP opens the door for hepatitis B virus infection
Huan Yan et al.
ANTIVIRAL RESEARCH (2015)
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years
Maria Buti et al.
HEPATOLOGY INTERNATIONAL (2015)
Immigration and viral hepatitis
Suraj Sharma et al.
JOURNAL OF HEPATOLOGY (2015)
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
JOURNAL OF HEPATOLOGY (2015)
Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection
Kai Dai et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Christopher Koh et al.
LANCET INFECTIOUS DISEASES (2015)
Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy
Chloe L. Thio et al.
LANCET INFECTIOUS DISEASES (2015)
Is mother-to-infant transmission the most important factor for persistent HBV infection?
Zixiong Li et al.
EMERGING MICROBES & INFECTIONS (2015)
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
Maria Buti et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Hepatitis B Virus and Hepatitis C Virus Infections in United States-Bound Refugees from Asia and Africa
Tonya Mixson-Hayden et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Ali A. Mokdad et al.
BMC MEDICINE (2014)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
W. -K. Seto et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim et al.
GUT (2014)
Telbivudine or Lamivudine Use in Late Pregnancy Safely Reduces Perinatal Transmission of Hepatitis B Virus in Real-Life Practice
Hua Zhang et al.
HEPATOLOGY (2014)
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
Wai-Kay Seto et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Health related quality of life in people with advanced chronic liver disease
James G. Orr et al.
JOURNAL OF HEPATOLOGY (2014)
Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen
M. Jiang et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Management of hepatitis B during pregnancy
Heather Patton et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Immunoprophylaxis Failure Against Vertical Transmission of Hepatitis B Virus in the Chinese Population A Hospital-based Study and a Meta-analysis
Xiaofang Lin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Update on hepatitis B virus infection
Chan Ran You et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatitis B virus genotypes: Global distribution and clinical importance
Mustafa Sunbul
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection
Cai-Feng Chen et al.
SCIENTIFIC REPORTS (2014)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
New insights into how HBV manipulates the innate immune response to establish acute and persistent infection
Peter Revill et al.
ANTIVIRAL THERAPY (2013)
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Pietro Lampertico et al.
GUT (2013)
A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant
Camille Sureau et al.
HEPATOLOGY (2013)
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy
Ching-Lung Lai et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Response-Guided Peginterferon Therapy in Hepatitis B e Antigen-Positive Chronic Hepatitis B Using Serum Hepatitis B Surface Antigen Levels
Milan J. Sonneveld et al.
HEPATOLOGY (2013)
Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis
Hua-Jie Dong et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
Stephane Chevaliez et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand-Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation
Sen Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Immunosuppression and HBV Reactivation
Daniel Shouval et al.
SEMINARS IN LIVER DISEASE (2013)
The Molecular Virology of Hepatitis B Virus
Dieter Glebe et al.
SEMINARS IN LIVER DISEASE (2013)
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV
Paola Fisicaro et al.
GASTROENTEROLOGY (2012)
Hepatitis B in the United States: A major health disparity affecting many foreign-born populations
John W. Ward et al.
HEPATOLOGY (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
HBsAg Inhibits IFN-α Production in Plasmacytoid Dendritic Cells through TNF-α and IL-10 Induction in Monocytes
Bisheng Shi et al.
PLOS ONE (2012)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Occult Hepatitis B Infection and HBV Replicative Activity in Patients with Cryptogenic Cause of Hepatocellular Carcinoma
Danny Ka Ho Wong et al.
HEPATOLOGY (2011)
Role of the Coinhibitory Receptor Cytotoxic T Lymphocyte Antigen-4 on Apoptosis-Prone CD8 T Cells in Persistent Hepatitis B Virus Infection
Anna Schurich et al.
HEPATOLOGY (2011)
Natural history of chronic hepatitis B REVEALed
Chien-Jen Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant Recipients
C. S. Coffin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
Vincent Rijckborst et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Altered T cell costimulation during chronic hepatitis B infection
Luisa Barboza et al.
CELLULAR IMMUNOLOGY (2009)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection
P. Fisicaro et al.
GUT (2009)
Hepatitis B Virus Suppresses Toll-like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells
Jun Wu et al.
HEPATOLOGY (2009)
Not Interferon, but Interleukin-6 Controls Early Gene Expression in Hepatitis B Virus Infection
Marianna Hoesel et al.
HEPATOLOGY (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2009)
Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination
Xiaofeng Liang et al.
VACCINE (2009)
Universal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone
Jia-Horng Kao et al.
AMERICAN JOURNAL OF MEDICINE (2008)
HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
Man-Fung Yuen et al.
GASTROENTEROLOGY (2008)
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2008)
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
Giovanna Fattovich et al.
JOURNAL OF HEPATOLOGY (2008)
Chronic Hepatitis B - New Goals, New Treatment
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels
M-F Yuen et al.
GUT (2008)
Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat 1
Min Wu et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions
Stefan Seitz et al.
EMBO JOURNAL (2007)
Brief report - The HBV drug entecavir - Effects on HIV-1 replication and resistance
Moira A. McMahon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B
Liangen Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
F. Bonino et al.
GUT (2007)
Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B
He-Jun Yuan et al.
JOURNAL OF INFECTION (2007)
Viral hepatitis in HIV infection
Margaret James Koziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Regulation of toll-like receptor-2 expression in chronic hepatitis B by the precore protein
Kumar Visvanathan et al.
HEPATOLOGY (2007)
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection
Atsushi Ozasa et al.
HEPATOLOGY (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
MF Yuen et al.
GUT (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Genomic analysis of the host response to hepatitis B virus infection
S Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection
SH Zhou et al.
JOURNAL OF VIROLOGY (2004)
Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants
AA Wagner et al.
AIDS (2004)
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees
SF Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B:: Implications for immunotherapy
GJM Webster et al.
JOURNAL OF VIROLOGY (2004)
Survival in patients with HIV infection and viral hepatitis B or C: a cohort study
M Bonacini et al.
AIDS (2004)
Prognostic factors in severe exacerbation of chronic hepatitis B
MF Yuen et al.
CLINICAL INFECTIOUS DISEASES (2003)
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment
EJ Wherry et al.
JOURNAL OF VIROLOGY (2003)
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection
D Milich et al.
HEPATOLOGY (2003)
Recombinant hepatitis B vaccine (Engerix-B (R)) - A review of its immunogenicity and protective efficacy against hepatitis B
GM Keating et al.
DRUGS (2003)
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
RJ Fontana et al.
GASTROENTEROLOGY (2002)
Prevalence of fatigue in general practice
W Cullen et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2002)
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
FY Yao et al.
HEPATOLOGY (2001)
Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms
GJM Webster et al.
HEPATOLOGY (2000)
Hepatitis B virus biology
C Seeger et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Share Paper
